Mono

Mono
Name	Infectious mononucleosis
Caption	Peripheral blood smear showing atypical lymphocytes
Field	Infectious disease
Symptoms	Fever, pharyngitis, lymphadenopathy, fatigue
Complications	Splenic rupture, airway obstruction, myocarditis
Onset	Acute
Causes	Epstein–Barr virus, cytomegalovirus, others
Diagnosis	Heterophile antibody test, PCR, serology
Treatment	Supportive care, steroids for severe complications
Frequency	Common among adolescents and young adults

Mono

Infectious mononucleosis is an acute, usually self-limited syndrome characterized by fever, sore throat, lymphadenopathy, and profound fatigue. The condition is most frequently caused by the Epstein–Barr virus and is notable for its characteristic atypical lymphocytosis and heterophile antibody response. Historically significant in clinical medicine, the syndrome has been described in association with various viral pathogens and has influenced understanding of host–virus interactions, hematology, and public health.

Definition and Terminology

Infectious mononucleosis denotes a clinical syndrome historically labeled "glandular fever" and "kissing disease" in popular literature. Key terms used in academic and clinical contexts include "heterophile-positive mononucleosis" when the Paul–Bunnell or Monospot test is positive and "heterophile-negative mononucleosis" when serologic assays for specific agents such as Epstein–Barr virus or cytomegalovirus are required. Nomenclature appears across textbooks from institutions like Mayo Clinic, Johns Hopkins Hospital, and in classifications by bodies such as the World Health Organization.

Etiology and Pathogens

The principal etiologic agent is Epstein–Barr virus, a member of the Herpesviridae family. Other viral causes include cytomegalovirus and, less commonly, agents such as human immunodeficiency virus during acute seroconversion, and various adenoviruses and hepatitis viruses in sporadic reports. Bacterial mimics may include Streptococcus pyogenes causing pharyngitis and abscesses. Associations with oncologic sequelae have linked Epstein–Barr virus to neoplasms like Burkitt lymphoma, Hodgkin lymphoma, and nasopharyngeal carcinoma described in populations such as those in Southern China and Equatorial Africa.

Epidemiology and Risk Factors

Incidence peaks in adolescents and young adults, with seroprevalence rising in childhood in low-resource settings and later in high-income countries. Epidemiologic patterns are documented in cohort studies from centers like Centers for Disease Control and Prevention and population surveys in countries including United States, United Kingdom, and Australia. Risk factors for symptomatic illness include delayed primary infection, close interpersonal contact exemplified by outbreaks in college dormitories and military barracks, and immunosuppression seen in patients at Massachusetts General Hospital and transplant centers. Blood transfusion and organ transplantation are documented routes for transmission in reports from European Centre for Disease Prevention and Control datasets.

Clinical Presentation and Complications

Typical presentation comprises fever, exudative pharyngitis, posterior cervical lymphadenopathy, and marked fatigue, as emphasized in clinical guides from Cleveland Clinic and NHS England. Hepatosplenomegaly and mild transaminase elevations are common; rare but severe complications include splenic rupture observed in military recruits and athletes, airway obstruction requiring tracheostomy reported in case series from Mayo Clinic, and hematologic complications such as autoimmune hemolytic anemia described in hematology literature from American Society of Hematology. Cardiac and neurologic complications—myocarditis, Guillain–Barré syndrome—have been reported in case reports in journals associated with Royal College of Physicians.

Diagnosis and Laboratory Findings

Diagnosis integrates clinical features with laboratory testing: heterophile antibody tests (Monospot) frequently used in emergency departments, and specific serologic assays for Epstein–Barr virus viral capsid antigen IgM/IgG, Epstein–Barr nuclear antigen in virology labs at Stanford University School of Medicine. Polymerase chain reaction assays for viral DNA enhance sensitivity in immunocompromised patients in transplant centers like Johns Hopkins Hospital. Peripheral blood typically shows atypical lymphocytosis documented in hematopathology references from Mayo Clinic Laboratories; liver function tests reveal mild transaminase elevation similar to patterns reported by American Association for the Study of Liver Diseases.

Treatment and Management

Management is largely supportive: rest, analgesia, and hydration as recommended by clinical guidelines from National Institute for Health and Care Excellence and American Academy of Pediatrics. Corticosteroids are indicated for significant tonsillar hypertrophy causing airway compromise or severe hemolytic anemia, with dosing regimens discussed in case series from tertiary centers such as Mount Sinai Hospital. Antiviral therapy for Epstein–Barr virus has limited efficacy in uncomplicated cases; investigational antiviral and immunotherapeutic approaches are reported from clinical trials registered with National Institutes of Health. Activity restriction to reduce risk of splenic rupture is emphasized in sports medicine recommendations from American College of Sports Medicine.

Prevention and Prognosis

No licensed vaccine is currently available despite research programs at institutions like Johns Hopkins University and pharmaceutical efforts documented in trials by National Institutes of Health. Preventive advice centers on limiting saliva exposure and careful screening in blood banks coordinated by organizations such as American Red Cross and World Health Organization transfusion services. Prognosis is generally excellent, with most patients achieving full recovery over weeks to months; persistent post-viral fatigue syndromes and rare chronic active Epstein–Barr virus disease are described in longitudinal studies from Centers for Disease Control and Prevention and specialty clinics at University of California, San Francisco.

Category:Viral diseases